Biblio
2024
Stathis A, Pirosa MCristina, Orsucci L, Feugier P, Tani M, Ghesquières H, Musuraca G, Rossi FGaia, Merli F, Guieze R, et al. IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Haematologica. 2024.
Rossini B, Cecchi N, Clemente F, De Paolis MRosaria, Hohaus S, Innao V, Lucignano M, Massaiu R, Palumbo G, Rigolin GMatteo, et al. Real-practice management and treatment of idiopathic multicentric Castleman disease with siltuximab: a collection of clinical experiences. Drugs Context. 2024;13.
2023
Chiappella A, Dodero A, Evangelista A, Re A, Orsucci L, Usai SVeronica, Castellino C, Stefoni V, Pinto A, Zanni M, et al. Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study. Leukemia. 2023.